Engaging with communities to encourage adoption of a harm reduction approach to COVID-19.

Margaret Hellard, David Motorniak, Wai Chung Tse, Freya Saich, Mark Stoové

Open access · goldAbstract read

In one paragraph

Article in Australian and New Zealand journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.3field-weighted citation impact, top 46% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

The managers' perspectives on service providing in women's harm reduction centers during the COVID-19 pandemic: mixed method study.Harm reduction journal · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Margaret HellardDisease Elimination Program, Burnet Institute, Melbourne, VIC, 3004, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia. Electronic address: Hellard@burnet.edu.au.

David MotorniakDisease Elimination Program, Burnet Institute, Melbourne, VIC, 3004, Australia.

Wai Chung TseDisease Elimination Program, Burnet Institute, Melbourne, VIC, 3004, Australia. Electronic address: waichung.tse@monash.edu.

Freya SaichDisease Elimination Program, Burnet Institute, Melbourne, VIC, 3004, Australia.

Mark StoovéDisease Elimination Program, Burnet Institute, Melbourne, VIC, 3004, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia.

Burnet Institute · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the emergence of the Omicron variant in Australia in late 2021 there have been over 5.47 million cases and 4993 deaths, disproportionately impacting on people with social and structural disadvantage. However there has been increasing reluctance by governments to intervene to reduce the impact of COVID-19 transmission and its consequences. This commentary article provides a perspective on the support and guidance required to mitigate individuals and communities risk by using a harm reduction approach to highlight strategies that can reduce COVID-19 transmission and infection.

Indexed as

COVID-19AustraliaHarm ReductionHumansSARS-CoV-2CALD CommunitiesCOVID-19harm reduction

Identifiers

PMID36963122

DOI10.1016/j.anzjph.2023.100022

PMCPMC10031063

OpenAlexW4353109169

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.